Contract sales & marketing

Partnership puts Israel on the AI and computational science map

08-Jan-2024 By Liza Laws

AION Labs, the first-of-its-kind venture studio today (January 8) announced its new partnership with Amiti Ventures, a leading early-stage venture capital firm in Israel.

BMS buys Karuna Therapeutics for $14 billion in deal that includes schizophrenia treatment

02-Jan-2024 By Liza Laws

Bristol Myers Squibb has announced it has acquired Karuna Therapeutics, Inc., for a total equity value of $14 billion or $12.7 billion net of estimated cash.

Deep Apple Therapeutics raises $52 million for small molecule therapeutics discovery

14-Dec-2023 By Liza Laws

A portfolio company created and incubated by Apple Tree Partners (ATP) has raised $52 million in series A funding to enable it to rapidly discover novel small molecule therapeutics.

Atropos Health and SEQESTER partner to save time, money and accelerate drug development

14-Dec-2023 By Liza Laws

Patient centric, healthcare data tech company, SEQESTER says it can now deliver real-time and real-world data layering in artificial intelligence (AI) to accelerate drug discovery, thanks to its partnership with Atropos Health.

Women in Science: An instant passion for science and thriving in a male-dominated industry

13-Dec-2023 By Liza Laws

Lisa Sellers is the CEO of Vector Laboratories, and she is passionate about staying ahead of the pharma trends.

Merck's first ever AI solution has more than 60 billion possibilities for successful drug properties

11-Dec-2023 By Liza Laws

Science and technology giant, Merck, has launched its first software-as-a-service (SaaS) platform that it says bridges the gap between virtual molecule design and real-world manufacturability.

Flywheel and Microsoft collaborate to unlock powerful data insights in medical imaging

23-Nov-2023 By Liza Laws

Healthcare breakthroughs have long-standing barriers when it comes to unlocking the powerful insights trapped in medical imaging data.

Prange Group and Adragos Pharma to acquire Fresenius Kabi’s Norwegian manufacturing site

17-Nov-2023 By Liza Laws

Definitive agreements with Fresenius Kabi have been signed by Prange Group and its affiliate Adragos Pharma for its sterile pharmaceutical production site in Halden, Norway.

Sosei Heptares and Kallyope collaboration milestone with first GPCR target

10-Nov-2023 By Liza Laws

The first scientific milestone stemming from a collaboration between Sosei Heptares and Kallyope that was announced last year (2022) has been reached.

Amcor launches new sustainable medical laminates solutions

08-Nov-2023 By Liza Laws

Amcor has taken a significant step towards sustainability by launching the next generation of its medical laminates solutions.

Interview: CEO Matt Walz and what's creating the buzz around Trialbee

08-Nov-2023 By Liza Laws

Matt Walz is CEO at Trialbee and has more than 20 years of software and leadership experience in the life sciences industry.

Curavit capturing health economics evidence with new HEOR practice

06-Nov-2023 By Liza Laws

With rising healthcare costs and ‘less understood digital therapeutics’ Curavit has launched a health economics and outcomes research (HEOR) practice.

Empatica and the importance of wearable devices in getting the full patient profile

20-Oct-2023 By Liza Laws

Matteo Lai was part of a panel at DPharm in Boston this year, it was called working together to accelerate the adoption of digital biomarkers in clinical trials.

DPHARM 2023

Greenphire's Dave Hine's reflections on DPharm 2023 - and how 'rising tide lifts all boats'

20-Oct-2023 By Liza Laws

Dave Hine is the senior director of sales engineering at Greenphire. He has been reflecting on his time at DPharm and the collaborative approach to life sciences.

Interview: EDETEK's Munther Baara on the paradigm shift in clinical trials

12-Oct-2023 By Liza Laws

Munther Baara has worked in the life sciences arena for more than 30 years. He has always been completely committed.

Mahana Therapeutics and Bayer in multi-million dollar partnership to commercialize digital therapeutics

24-Aug-2023 By Liza Laws

Mahana Therapeutics announced last week (August 22) that it was entering into a multi-million dollar distribution and marketing partnership with the consumer health division of Bayer.

Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation

21-Aug-2023 By Liza Laws

Novartis’ board of directors has unanimously agreed to separate Sandoz as a 100 per cent spin-off with a $15 billion share buyback.

Advanced Clinical to host event looking at increasing clinical research talent at DIA 2023

14-Jun-2023 By Liza Laws

In a bid to address the high demand for clinical research talent, Advanced Clinical is hosting an innovation theater at DIA Global in Boston’s Convention and Exhibition Center.

Strateos shifts strategy to on-site cloud labs

24-Apr-2023 By Ben Hargreaves

The company announces plans to reorganize its business to focus on design-and-deployment engagements for on-site implementation of automated cloud labs.

ClinOne closes $3M series A funding and welcomes new board memeber

18-Apr-2023 By Liza Laws

A company providing a single platform to support clients’ clinical trial journeys has closed a $3 million Series A funding.

Investment firm launches CDMO after Pfizer facility buyout

11-Apr-2023 By Ben Hargreaves

Bridgewest launches a new CDMO that will be branded NovaCina, operating out of Australia and specializing in sterile injectable drug products.

Operio makes manufacturing acquisition with European expansion aim

11-Apr-2023 By Ben Hargreaves

Operio has acquired a group of companies that provide both manufacturing equipment and services in the solid dose space.

Zebra adds new environmental sensors for pharma supply chain

23-Mar-2023 By Ben Hargreaves

The company launches its new ZS300 sensor, ZB200 bridge and Android sensor discovery app, which will be made available for use with the supply chains of the pharma and food industries.

Piramal begins production at API facility in Michigan

20-Feb-2023 By Ben Hargreaves

The Indian company begins production of APIs and HPAPIs, after expanding capacity at its Riverview site.

AZ blames UK tax for Ireland API plant decision

13-Feb-2023 By Ben Hargreaves

The company’s CEO stated that a ‘discouraging tax rate’ was behind the decision to build a $360m API plant in Ireland rather than the UK.

Pasithea agrees manufacturing deal with WuXi STA

24-Jan-2023 By Ben Hargreaves

The CDMO will manufacture the API for the biotech’s lead drug candidate, ahead of plans to begin clinical trials.

Eurofins relocates to expand API capabilities in Canada

17-Jan-2023 By Ben Hargreaves

Eurofins announces that it relocated and expanded its API development laboratories by moving to a new space in Ontario, Canada.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Will biotech see an uptick in M&A?

19-Jul-2022 By Rachel Arthur

The biopharma M&A market has slowed since 2019. But is a buyer’s market emerging?

Building resilience into biotech supply chains: 'COVID-19 will not be the last major crisis of the 21st century'

08-Jul-2022 By Rachel Arthur

Biotech supply chains face an uncertain future in 2022 and beyond: up against myriad challenges ranging from future pandemic outbreaks to geopolitical tensions – and, indeed, unforeseen threats. Communication and collaboration between policymakers and...

EY biotech report checks in on the mood of industry leaders

23-Jun-2022 By Jenni Spinner

The 32nd iteration of the company’s Beyond Borders report offers an in-depth look at the state of the current market landscape, and what’s on the horizon.

CPhI North America 2022

Pharma growth, partnerships focus of 2022 CPhI North America

04-May-2022 By Jenni Spinner

A leader from the organizer of the pharmaceutical event discusses what’s in store for the upcoming conference, and for the drug development industry itself.

CPHI NORTH AMERICA 2022

US pharma hubs: The rising stars to watch

04-May-2022 By Rachel Arthur

CPhI North America 2022 host city Philadelphia is set to become one of the world’s biggest cell and gene therapy manufacturing hubs. But it’s just one of many centers of innovation that are helping drive the US pharma and biopharma industry.

Yourway adds 100k square feet of temp-controlled storage capacity

28-Apr-2022 By Jenni Spinner

The addition of the facility in Pennsylvania will help meet the increasing demand for temperature-controlled clinical packaging, storage, and distribution.

Bayer program streamlines clinical trial process, site relationships

17-Feb-2022 By Jenni Spinner

Created via a joint effort with EY, the pharmaceutical company launched ASPIREs, a program intended to improve its clinical trial processes in numerous areas.

Merck restructures to strengthen CDMO business

14-Feb-2022 By Jane Byrne

Darmstadt, Germany headquartered, Merck KGaA, is restructuring its life sciences business.

SCOPE 2022

Clinical management platform enables vendor visibility: Strategikon Pharma

08-Feb-2022 By Jenni Spinner

Vision, part of the company’s Clinical Maestro platform of software-as-a-solution applications, enables study teams to manage clinical vendor oversight.

SCOPE 2022

Bright ideas, new partnerships, and fun on tap at SCOPE 2022

26-Jan-2022 By Jenni Spinner

The upcoming industry event offers attendees (in-person and virtual) a range of opportunities to learn, connect, and innovate, according to an organizer.

Pharma R&D investment report shows positive signs: Deloitte

14-Jan-2022 By Jenni Spinner

According to the company’s 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

FourKites, Accenture survey dives into supply chain concerns

10-Jan-2022 By Jenni Spinner

Checking in with pharma executives, the survey outlines leaders’ thoughts about current and future challenges, like costs, security, and inventory control.

People on the Move: December 2021

02-Dec-2021 By Jenni Spinner

This month’s announcements of awards, expansions, name changes, hires, and other news includes items from CPhI, Almac Group, ICON, and other organizations.

Use of robotics in pharma packaging, manufacturing on the rise: Beroe

10-Nov-2021 By Jenni Spinner

According to the market intelligence firm, automation appeals to drug packaging and manufacturing firms, thanks to their productivity-boosting potential.

Pharmaceutical packaging firm adds QC laboratory in Ireland

10-Nov-2021 By Jenni Spinner

Wasdell, a UK-based packaging and manufacturing provider in the UK, has opened a quality control laboratory in Dundalk to analyze products for its pharmaceutical clientele.

CPHI WORLDWIDE

Pharmaceutical industry confidence on the rise: CPhI Worldwide

09-Nov-2021 By Jenni Spinner

At the open of the global pharmaceutical industry gathering, a survey of executives from around the globe indicates a rosy mood among professionals in the field.

Notre Dame lab partners with Artifacts to halt substandard generics

21-Oct-2021 By Jenni Spinner

The Distributed Pharmaceutical Analysis Lab and the blockchain-based platform provider will work to prevent fake and low-quality drugs from circulating.

‘Digital transformation’ requires enterprise-wide change: Rockwell Automation

19-Oct-2021 By Jenni Spinner

To fully reap the benefits of tech advances, a company leader advises, a life-sciences firm must embrace change and connection throughout the operation.

People on the Move: October 2021

07-Oct-2021 By Jenni Spinner

This month’s news on appointments, expansions, acquisitions and other events includes Nanoform, Elligo Health Research, Curavit, and other organizations.

cphi north america 2021

Report: expect the future of US pharma market to be ‘exciting’

04-Aug-2021 By Jenni Spinner

An industry study from the producer of CPhI North America shows the pandemic and other factors are contributing to a very dynamic pharmaceutical market.

Pharma industry, CROs adapting to COVID-19 impacts: survey

27-Jul-2021 By Jenni Spinner

A recent check-in with several biopharma and CRO companies, conducted by Life Science Strategy Group, indicates adjustment to pandemic-related challenges.

Contract data analysis can help predict pharma demand: Agiloft

Contract data analysis can help predict pharma demand: Agiloft

19-Jul-2021 By Jenni Spinner

The process management solutions firm says drug companies could use contract data to get a better handle on predicting demand and adjusting product output.